ClinicalTrials.govpublic full text
Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of PLX-200 in Pediatric Patients (Master Protocol)
lysosomal storage disorders, sandhoff disease, krabbe disease, cln2, cln3, pediatric, lsd, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 806267
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.